No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

Renal insufficiency refers to a state in which the kidneys are not functioning at their full capacity. This condition may be ...

“We look forward to the results and plan to educate the public over the next few months on the importance of the planned biomarkers as it relates to CKD treatment and prevention of AKI.

Chronic kidney disease (CKD) is a reputed risk factor for development of acute kidney injury (AKI) during hospitalization. This concept is based on studies in which baseline kidney function was ...

Medscape Nephrology, January 13, 2017 Disparities in Renal Replacement and Dialysis Therapies Dr Jeffrey Berns comments on three articles examining the provision of dialysis services to patients ...

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally ...